WallStSmart

Comfort Systems USA Inc (FIX)vsVertex Pharmaceuticals Inc (VRTX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Vertex Pharmaceuticals Inc generates 21% more annual revenue ($12.22B vs $10.14B). VRTX leads profitability with a 35.5% profit margin vs 12.1%. FIX appears more attractively valued with a PEG of 0.93. VRTX earns a higher WallStSmart Score of 68/100 (B-).

FIX

Buy

62

out of 100

Grade: C+

Growth: 8.0Profit: 8.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 3.14

VRTX

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.7Quality: 8.5
Piotroski: 3/9Altman Z: 3.61
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for FIX.

VRTXUndervalued (+52.4%)

Margin of Safety

+52.4%

Fair Value

$949.55

Current Price

$446.83

$502.72 discount

UndervaluedFair: $949.55Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FIX6 strengths · Avg: 9.0/10
Return on EquityProfitability
43.5%10/10

Every $100 of equity generates 43 in profit

Altman Z-ScoreHealth
3.1410/10

Safe zone — low bankruptcy risk

Market CapQuality
$68.68B9/10

Large-cap with strong market position

Debt/EquityHealth
0.129/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.938/10

Growing faster than its price suggests

EPS GrowthGrowth
38.8%8/10

Earnings expanding 38.8% YoY

VRTX6 strengths · Avg: 9.7/10
Profit MarginProfitability
35.5%10/10

Keeps 36 of every $100 in revenue as profit

Operating MarginProfitability
38.1%10/10

Strong operational efficiency at 38.1%

EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

Altman Z-ScoreHealth
3.6110/10

Safe zone — low bankruptcy risk

Market CapQuality
$114.33B9/10

Large-cap with strong market position

Return on EquityProfitability
22.4%9/10

Every $100 of equity generates 22 in profit

Areas to Watch

FIX3 concerns · Avg: 2.7/10
Revenue GrowthGrowth
1.0%4/10

1.0% revenue growth

P/E RatioValuation
56.5x2/10

Premium valuation, high expectations priced in

Price/BookValuation
100.4x2/10

Trading at 100.4x book value

VRTX3 concerns · Avg: 3.7/10
PEG RatioValuation
1.694/10

Expensive relative to growth rate

P/E RatioValuation
26.7x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : FIX

The strongest argument for FIX centers on Return on Equity, Altman Z-Score, Market Cap. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : VRTX

The strongest argument for VRTX centers on Profit Margin, Operating Margin, EPS Growth. Profitability is solid with margins at 35.5% and operating margin at 38.1%.

Bear Case : FIX

The primary concerns for FIX are Revenue Growth, P/E Ratio, Price/Book. A P/E of 56.5x leaves little room for execution misses.

Bear Case : VRTX

The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

FIX profiles as a value stock while VRTX is a mature play — different risk/reward profiles.

FIX carries more volatility with a beta of 1.67 — expect wider price swings.

VRTX is growing revenue faster at 7.8% — sustainability is the question.

VRTX generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

VRTX scores higher overall (68/100 vs 62/100), backed by strong 35.5% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Comfort Systems USA Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Comfort Systems USA, Inc. provides mechanical and electrical installation, renovation, maintenance, repair and replacement services for the mechanical and electrical service industry in the United States. The company is headquartered in Houston, Texas.

Vertex Pharmaceuticals Inc

HEALTHCARE · BIOTECHNOLOGY · USA

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

Want to dig deeper into these stocks?